|
|
| TRIUMPH: A Phase III International Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Ti |
TRIUMPH: A Phase III International Study to Assess the Safety and Efficacy of Nitric Oxide
Synthase Inhibition with Tilarginine Acetate Injection in Patients with Cardiogenic Shock
Complicating Acute Myocardial Infarction
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|